Bussiness3 months ago
BridgeBio Pharma Reports Second Quarter 2024 Financial Results and Business Update
BridgeBio Pharma, Inc. Acoramidis demonstrated a significant impact on mortality, hospitalizations, and quality of life Starting at Month 3, patients taking acoramidis showed meaningful and sustained improvement in time...
